U.S. MARKETS FOR CARDIAC RHYTHM MANAGEMENT

118 Pages | 33 Exhibits | 2015 Analysis | Forecasts Through 2019 Product Family: Market Reports




OVERVIEW:
Cardiac rhythm management (CRM) devices, which encompasses diagnostic and therapeutic systems, represents a well-established market that is still seeing innovation in some of the segments that compose it. Over the forecast period covered in this report, the estimated value of the U.S. market for CRM devices is expected to grow by approximately $1.1 billion at compound annual growth rate (CAGR) of 2.9%; of this holistic market, diagnostic CRM products are forecasted to grow at a CAGR of 4.8%, while therapeutic CRM products will grow at a CAGR of 2.7%.

Contents of this report include:
•    Procedure and market forecasts for the years 2014 to 2019;
•    Key factors influencing the growth of individual product markets;
•    Estimated market shares and sales among major U.S. suppliers;
•    Major supplier product portfolio analysis in individual product markets; and,
•    Innovative technology that could potentially change the way product markets develop.

The scope of the analysis of this report covers diagnostic and therapeutic modalities used in the management of cardiac rhythm disorders. Diagnostic modalities covered in this report include electrocardiography (ECG) systems and electrophysiology (EP) catheters. Therapeutic modalities discussed in this report include ablation catheters (surgical and transcatheter), cardiac resynchronization therapy (CRT) systems, external defibrillators, implantable cardioverter defibrillators (ICDs), and pacemakers.

TABLE OF CONTENTS:
EXECUTIVE SUMMARY

i. Methodology

Exhibit ES-1: 2014, U.S. Cardiac Rhythm Management Market, Share by Products

1. CARDIAC RHYTHM DISORDERS OVERVIEW

1.1 The Heart and Circulatory System
1.2 The Cardiac Conduction System
1.3 Selected Cardiac Rhythm Disorders
	1.3.1 Bradycardia
	1.3.2 Sick Sinus Syndrome
	1.3.3 Heart Block
	1.3.4 Tachycardia
	1.3.5 Atrial Fibrillation
	1.3.6 Ventricular Fibrillation

Exhibit 1-1: Cross-Section Diagrams of the Heart Illustrating the Direction of Blood Flow during Diastole and Systole
Exhibit 1-2: Cross-Section Diagrams of the Heart Valve Positions during Diastole and Systole
Exhibit 1-3: Diagram of Selected Coronary Arteries
Exhibit 1-4: Diagram of Cardiac Conduction System
Exhibit 1-5: Cardiac Arrhythmias, Selected Statistics

2. U.S. MARKETS FOR CARDIAC RHYTHM MANAGEMENT DEVICES

2.1 Diagnostic Cardiac Rhythm Management Devices, Market Analysis
	2.1.1 Electrocardiography Products, Market Analysis
		2.1.1.1 Procedure Volumes
		2.1.1.2 Products
		2.1.1.3 Market Forecast
		2.1.1.4 Competitive Analysis
	2.1.2 Electrophysiology Products, Market Analysis
		2.1.2.1 Procedure Volumes
		2.1.2.2 Products
		2.1.2.3 Market Forecast
		2.1.2.4 Competitive Analysis
2.2 Therapeutic Cardiac Rhythm Management Devices, Market Analysis
	2.2.1 Cardiac Resynchronization Therapy Products, Market Analysis
		2.2.1.1 Implantable Cardiac Pacing Systems
		2.2.1.2 Temporary Pacing Systems
		2.2.1.3 Procedure Volumes
		2.2.1.4 Products
		2.2.1.5 Market Forecast
		2.2.1.6 Competitive Analysis
	2.2.2 External Defibrillator Products, Market Analysis
		2.2.2.1 Placement Volumes
		2.2.2.2 Products
		2.2.2.3 Market Forecast
		2.2.2.4 Competitive Analysis
	2.2.3 Implantable Cardioverter Defibrillator Products, Market Analysis
		2.2.3.1 Procedure Volumes
		2.2.3.2 Products
		2.2.3.3 Market Forecast
		2.2.3.4 Competitive Analysis
	2.2.4 Cardiac Resynchronization Therapy, Market Analysis
		2.2.4.1 Cardiac Resynchronization Therapy Systems
		2.2.4.1 Procedure Volumes
		2.2.4.2 Products
		2.2.4.3 Market Forecast
		2.2.4.4 Competitive Analysis
	2.2.5 Arrhythmia Ablation
		2.2.5.1 Transcatheter Arrhythmia Ablation
		2.2.5.2 Transcatheter Ablation of Atrial Fibrillation
		2.2.5.3 Direct Energy-Based Surgical Ablation of Atrial Fibrillation
		2.2.5.4 Procedure Volumes
		2.2.5.5 Products
		2.2.5.6 Market Forecast
		2.2.5.7 Competitive Analysis

Exhibit 2-1: Cardiac Rhythm Management, Combined Procedure Volumes Forecast, 2014-2019
Exhibit 2-2: Cardiac Rhythm Management Products, Combined Market Forecast, 2014-2019
Exhibit 2-3: Normal Electrocardiogram Tracing
Exhibit 2-4: Electrocardiography, Procedure Volumes Forecast, 2014-2019
Exhibit 2-5: Electrocardiography Products, Market Forecast, 2014-2019
Exhibit 2-6: 2014, Electrocardiography Products Market, Share by Supplier
Exhibit 2-7: Diagnostic Electrophysiology, Procedure Volumes Forecast, 2014-2019
Exhibit 2-8: Electrophysiology Systems, Market Forecast, 2014-2019
Exhibit 2-9: 2014, Electrophysiology Products Market, Share by Supplier
Exhibit 2-10: NBG Code for Implantable Pacemaker Systems
Exhibit 2-11: Cardiac Pacemaker Implantation, Procedure Volumes Forecast, 2014-2019
Exhibit 2-12: Pacemaker Products, Market Forecast, 2014-2019
Exhibit 2-13: 2014, Pacemaker Products Market, Share by Supplier
Exhibit 2-14: External Defibrillation, Placement Volumes Forecast, 2014-2019
Exhibit 2-15: External Defibrillator Products, Market Forecast, 2014-2019
Exhibit 2-16: 2014, External Defibrillator Products Market, Share by Supplier
Exhibit 2-17: NBD Code and Labeling for Implantable Cardioverter Defibrillators
Exhibit 2-18: Implantable Cardioverter Defibrillator Implantation, Procedure Volumes Forecast, 2014-2019
Exhibit 2-19: Implantable Cardioverter Defibrillator Products, Market Forecast, 2014-2019
Exhibit 2-20: 2014, Implantable Cardioverter Defibrillator Products Market, Share by Supplier
Exhibit 2-21: Cardiac Resynchronization Therapy, Procedure Volumes Forecast, 2014-2019
Exhibit 2-22: Cardiac Resynchronization Therapy Products,  Market Forecast, 2014-2019
Exhibit 2-23: 2014, Cardiac Resynchronization Therapy Products Market, Share by Supplier
Exhibit 2-24: Cardiac Ablation, Procedure Volumes Forecast, 2014-2019
Exhibit 2-25: Cardiac Ablation Products, Market Forecast, 2014-2019
Exhibit 2-26: 2014, Transcatheter Ablation Systems Products Market, Share by Supplier
Exhibit 2-27: 2014, Surgical Ablation Systems Products Market, Share by Supplier

APPENDIX:  COMPANY LISTING


COMPANIES COVERED:

  1. Abbott Laboratories/Abbott
  2. Aerotel
  3. AMD Global Telemedicine
  4. Arrow International/Teleflex Medical/Teleflex
  5. Asahi Kasei Corporation
  6. AtriCure
  7. Biosense Webster/Johnson & Johnson
  8. Biotronik
  9. Boston Scientific
  10. Cardiac Science/Opto Circuits
  11. Cardioline
  12. Defibtech/Nihon Kohden America
  13. Edan USA/Edan Instruments
  14. Estech/AtriCure
  15. Fukuda Denshi USA/Fukuda Denshi
  16. GE Healthcare/General Electric
  17. HeartSine
  18. iRhythm Technologies
  19. Johnson & Johnson
  20. Medtronic
  21. Mortara Instrument
  22. nContact
  23. Nihon Kohden America/Nihon Kohden
  24. Opto Circuits
  25. Philips Healthcare/Royal Philips
  26. Physio-Controll
  27. Schiller America/Schiller
  28. Sorin Group
  29. St. Jude Medical
  30. Teleflex Medical/Teleflex
  31. TZ Medical
  32. Welch Allyn
  33. Zoll Medical
Contact Us

Need help finding medtech research? Let us help you!